Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Formulation and In vitro Evaluation of Carvedilol Transdermal Delivery System

Pisipati Aparna¹ , Lyadella Divya¹, Kalva Bhadrayya², Chavali VS Subrahmanyam¹

¹Department of Pharmaceutics, Osmania University, Gokaraju Rangaraju College of Pharmacy, Jawaharlal Nehru Technological University, Hyderabad; ²Swaroop Tech Consultancy, Secunderabad, India.

For correspondence:- Pisipati Aparna Email: aparna16p@hotmail.com

Received: 10 April 2013 Accepted: 30 June 2013 Published: 23 August 2013

Citation: Aparna P, Divya L, Bhadrayya K, Subrahmanyam CV. Formulation and In vitro Evaluation of Carvedilol Transdermal Delivery System. Trop J Pharm Res 2013; 12(4):461-467 doi: 10.4314/tjpr.v12i4.3

© 2013 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To develop and optimize carvedilol transdermal delivery system.

Methods: Solvent casting method was used to prepare patches using polymethyl methacrylate (PMMA) and Eudragit E100 (EE100) polymers, dimethylsulfoxide (DMSO) penetration enhancer, dibutylphthalate (DBP) plasticizer and Tween 80 surfactant. A 2³ factorial design was used based on three variables (PMMA, EE100, DMSO). at two levels Second order polynomial equations indicating interplay of ingredients were obtained by factorial design using SigmaTech software for 1, 4, 8 and 20 h release data. so the design was extended to central composite design (CCD). The target formulation was obtained from contour plots and evaluated for various physicochemical parameters. including in-vitro dissolution studies.

Results: Curvature effect was observed in F1 to F8 formulations, highlighting the interplay of ingredients. The interaction term (X₂X₃)exhibited highest Sum of Squares SS ratio at 1, 4, and 8 h data with positive coefficients indicating interaction; and so extended to CCD. From contour plots target formulation, F19, was identified and evaluated. The release data, were subjected to kinetic analysis, which followed Higuchi (diffusion) model (R² = 0.9886).

Conclusion: F19 yielded release profile nearer to the theoretical predictions with R² of 0.9888 and followed Higuchi kinetics. Thus, a diffusion-mediated carvedilol matrix patch was successfully developed.

Keywords: Carvedilol, Central composite design, Drug release, Transdermal patch